Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Change in Account Payables (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Change in Account Payables for 7 consecutive years, with -$18.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 26.42% to -$18.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$854000.0, a 94.91% increase, with the full-year FY2025 number at -$854000.0, up 94.91% from a year prior.
  • Change in Account Payables was -$18.6 million for Q4 2025 at Select Medical Holdings, down from -$3.3 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $30.5 million in Q4 2021 to a low of -$27.1 million in Q3 2022.
  • A 5-year average of -$935250.0 and a median of -$2.8 million in 2023 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: soared 889.87% in 2021, then plummeted 771.06% in 2022.
  • Select Medical Holdings' Change in Account Payables stood at $30.5 million in 2021, then crashed by 184.84% to -$25.9 million in 2022, then surged by 56.68% to -$11.2 million in 2023, then crashed by 31.54% to -$14.7 million in 2024, then fell by 26.42% to -$18.6 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Change in Account Payables are -$18.6 million (Q4 2025), -$3.3 million (Q3 2025), and $7.6 million (Q2 2025).